New York, December 18, 2013 / Accesswire / - Market Buzz Report, which provides live alerts on penny stocks, issues critical stocks analysis for Advanced Micro Devices, Inc. (NYSE:AMD), Qihoo 360 Technology Co Ltd (NYSE:QIHU), ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD), Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA).
Advanced Micro Devices, Inc. (NYSE:AMD) shares declined 0.14% to $3.64. AMD‘s stock had its “neutral” rating reaffirmed by Zacks in a research report issued to clients and investors on Dec. 12. They currently have a $3.75 price target on the stock. Zacks‘ target price indicates a potential upside of 1.90% from the stock’s previous close.
Additionally, the company on Dec. 17 announced the AMD Radeon™ R7 260 graphics card, the newest addition to the AMD Radeon™ R7 Series GPUs, a family of GPUs designed for everyday gamers and people looking to boost the graphics performance of their PCs.
Free Urgent Insider Catalyst Report For AMD Available Here: http://marketbuzzreport.com/index.php?code=AMD (Or Copy and paste the URL into your browser)
Qihoo 360 Technology Co Ltd (NYSE:QIHU) shares gained 0.05% to $77.53. On Nov 29, Zacks Investment Research upgraded Qihoo (QIHU) to a Zacks Rank #1 (Strong Buy).
Additionally, the company on Nov. 24 reported its unaudited financial results for the quarter ended Sept. 30, 2013. Revenues were $187.9 million, an increase of 124% from $84.0 million in the 3Q2012 and an increase of 24% from $151.7 million in the 2Q2013. Net income attributable to Qihoo 360 was $44.5 million, compared to $12.9 million in the 3Q2012 and $33.0 million in the prior quarter. Non-GAAP Net income was $61.5 million, compared to $24.2 million in the 3Q2012 and $51.0 million in the prior quarter.
Free Urgent Insider Catalyst Report For QIHU Available Here: http://marketbuzzreport.com/index.php?code=QIHU (Or Copy and paste the URL into your browser)
ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) shares jumped 0.43% to $23.10. The company presented at the Piper Jaffray 25th Annual Healthcare Conference on Dec. 3, 2013, at 10:00 a.m. Eastern Time in New York City; and will present at the Oppenheimer 24th Annual Healthcare Conference on Dec. 10, 2013, at 8:35 a.m. Eastern Time in New York City.
Additionally, the company on Nov. 14 announced that it has initiated a Phase II feasibility trial designed to examine the efficacy and safety of pimavanserin as a treatment for patients with Alzheimer’s disease psychosis (ADP). No drug is approved in the United States to treat ADP and the off-label use of current antipsychotics is linked to increased mortality, serious adverse events, and cognitive decline in elderly patients with dementia-related psychosis.
Free Urgent Insider Catalyst Report For ACAD Available Here: http://marketbuzzreport.com/index.php?code=ACAD (Or Copy and paste the URL into your browser)
Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA) shares climbed 3.36% to $4.30. Levi & Korsinsky on Dec. 5 announces that a class action lawsuit has been commenced in the United States District Court for the District of Massachusetts on behalf of investors who purchased ARIAD Pharmaceuticals, Inc. ("ARIAD" or the "Company") (NASDAQ GS: ARIA) stock between December 12, 2011 and October 8, 2013. The Complaint alleges that throughout the Class Period defendants made false and misleading statements regarding the safety and efficacy of the leukemia drug Iclusig.
Free Urgent Insider Catalyst Report For ARIA Available Here: http://marketbuzzreport.com/index.php?code=ARIA (Or Copy and paste the URL into your browser)
USMarketBuzz.com is an investment community that Focuses on MicroCap Securities. USMarketBuzz.com is an authorative authentic Google News Site and Leading Provider of Investment Awareness and Featured Company Profiles. If you would like more information regarding our news coverage solutions, please visit http://www.USMarketBuzz.com/ for more details. Get an edge on the market with our Premium News Alerts that are FREE for a limited time at http://www.USMarketBuzz.com/. Follow us on Facebook: https://www.facebook.com/usmarket.buzz Sign up for our FREE SMS News alerts delivered directly to your mobile phone by texting the word PREPROMO to 27126. (SMS alerts are free, however data rates may apply, check your wireless plan for details.)